Anti-inflammatory effects of a p38 mitogen-activated protein kinase inhibitor during human endotoxemia.
Branger J, van den Blink B, Weijer S, Madwed J, Bos CL, Gupta A, Yong CL, Polmar SH, Olszyna DP, Hack CE, van Deventer SJ, Peppelenbosch MP, van der Poll T.
Branger J, et al. Among authors: van deventer sj, van der poll t, van den blink b.
J Immunol. 2002 Apr 15;168(8):4070-7. doi: 10.4049/jimmunol.168.8.4070.
J Immunol. 2002.
PMID: 11937566
Clinical Trial.